Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46281

1.

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.

Garassino MC, Crinò L, Catino A, Ardizzoni A, Cortesi E, Cappuzzo F, Bordi P, Calabrò L, Barbieri F, Santo A, Altavilla G, Ambrosio F, Mini E, Vasile E, Morgillo F, Scoppola A, Bengala C, Follador A, Tedde N, Giannarelli D, Lo Russo G, Vitiello F.

Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047.

PMID:
30486741
2.

Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.

Ye L, Xiang T, Zhu J, Li D, Shao Q, Peng W, Tang J, Li L, Ren G.

Cell Physiol Biochem. 2018;51(2):961-978. doi: 10.1159/000495399. Epub 2018 Nov 22.

3.

[Research Advances of Ang-2 in Non-small Cell Lung Cancer].

Hua X, Zhu X.

Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):868-874. doi: 10.3779/j.issn.1009-3419.2018.11.09. Review. Chinese.

4.

[Survival Analysis of Stage I Non-small Cell Lung Cancer Patients Treated with 
Da Vinci Robot-assisted Thoracic Surgery].

Liu X, Xu S, Liu B, Xu W, Ding R, Wang T, Li B, Wang X, Wu Q, Teng H, Wang S.

Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):849-856. doi: 10.3779/j.issn.1009-3419.2018.11.07. Chinese.

5.

[Disparities of EGFR mutations between Biopsy and Rebiopsy in Non-small Cell Lung Cancer Patients].

Li H, Yan S, Liu X, Liu Y, Ma L, Wang Y, Liu Y, Cheng Y.

Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):821-827. doi: 10.3779/j.issn.1009-3419.2018.11.03. Chinese.

6.

Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.

Hung WY, Chang JH, Cheng Y, Chen CK, Chen JQ, Hua KT, Cheng CW, Hsiao M, Chung CL, Lee WJ, Chien MH.

Cell Physiol Biochem. 2018;51(1):337-355. doi: 10.1159/000495233. Epub 2018 Nov 19.

7.

Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.

Luo M, Luo Y, Mao N, Huang G, Teng C, Wang H, Wu J, Liao X, Yang J.

Cell Physiol Biochem. 2018;51(1):315-336. doi: 10.1159/000495232. Epub 2018 Nov 19.

8.

Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.

Tian S, Liu DH, Wang D, Ren F, Xia P.

Cell Physiol Biochem. 2018;51(1):217-227. doi: 10.1159/000495202. Epub 2018 Nov 16.

9.

Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer.

Yu TM, Morrison C, Gold EJ, Tradonsky A, Arnold RJG.

Value Health. 2018 Nov;21(11):1278-1285. doi: 10.1016/j.jval.2018.04.1372. Epub 2018 Jun 8.

11.

Miliary Metastases in Non-Small-Cell Lung Cancer.

Patil T, Pacheco JM.

N Engl J Med. 2018 Nov 15;379(20):1945. doi: 10.1056/NEJMicm1803514. No abstract available.

PMID:
30428292
12.

Delineation of lung cancer with FDG PET/CT during radiation therapy.

Ganem J, Thureau S, Gardin I, Modzelewski R, Hapdey S, Vera P.

Radiat Oncol. 2018 Nov 12;13(1):219. doi: 10.1186/s13014-018-1163-2.

13.

Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient: A case report.

Li S, Zhang Y, Sun Z, Hu J, Fang C.

Medicine (Baltimore). 2018 Nov;97(45):e12907. doi: 10.1097/MD.0000000000012907.

14.

TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.

Li Y, Bai M, Xu Y, Zhao W, Liu N, Yu J.

Cell Physiol Biochem. 2018;50(5):2004-2016. doi: 10.1159/000494892. Epub 2018 Nov 7.

15.

MicroRNA-107 Targets IKBKG and Sensitizes A549 Cells to Parthenolide.

Moeng S, Seo HA, Hwang CY, Cipolla GA, Lee DJ, Kuh HJ, Park JK.

Anticancer Res. 2018 Nov;38(11):6309-6316. doi: 10.21873/anticanres.12987.

PMID:
30396951
16.

Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin.

Phiboonchaiyanan PP, Petpiroon N, Sritularak B, Chanvorachote P.

Anticancer Res. 2018 Nov;38(11):6281-6290. doi: 10.21873/anticanres.12984.

PMID:
30396948
17.

Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.

Gao L, He RQ, Wu HY, Zhang TT, Liang HW, Ye ZH, Li ZY, Xie TT, Shi Q, Ma J, Hu XH, Chen G.

Cell Physiol Biochem. 2018;50(5):1964-1987. doi: 10.1159/000494875. Epub 2018 Nov 5.

18.

[Efficacy and safety of anlotinib in 16 patients with advanced non-small cell lung cancer].

Si XY, Wang HP, Zhang XT, Wang MZ, Zhang L.

Zhonghua Nei Ke Za Zhi. 2018 Nov 1;57(11):830-834. doi: 10.3760/cma.j.issn.0578-1426.2018.11.007. Chinese.

PMID:
30392239
19.

Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.

Kaishang Z, Xue P, Shaozhong Z, Yingying F, Yan Z, Chanjun S, Zhenzhen L, Xiangnan L.

Life Sci. 2018 Dec 15;215:159-169. doi: 10.1016/j.lfs.2018.10.067. Epub 2018 Oct 31.

PMID:
30391462
20.

Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.

Dreyer J, Bremer M, Henkenberens C.

Radiat Oncol. 2018 Nov 3;13(1):213. doi: 10.1186/s13014-018-1156-1.

Supplemental Content

Loading ...
Support Center